HAL vs LMAT · P/E 9.3, $19.05B cap vs P/E 35, rev $219.9M
Halliburton Company (HAL) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the HAL and LMAT stock pages for the full models.
Not investment advice.